These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
826 related articles for article (PubMed ID: 15364803)
1. Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin. Kovacs MJ; Kearon C; Rodger M; Anderson DR; Turpie AG; Bates SM; Desjardins L; Douketis J; Kahn SR; Solymoss S; Wells PS Circulation; 2004 Sep; 110(12):1658-63. PubMed ID: 15364803 [TBL] [Abstract][Full Text] [Related]
2. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen. Douketis JD; Johnson JA; Turpie AG Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166 [TBL] [Abstract][Full Text] [Related]
3. Risk of thromboembolism with short-term interruption of warfarin therapy. Garcia DA; Regan S; Henault LE; Upadhyay A; Baker J; Othman M; Hylek EM Arch Intern Med; 2008 Jan; 168(1):63-9. PubMed ID: 18195197 [TBL] [Abstract][Full Text] [Related]
4. Anticoagulation interruptus: not without risk. Ezekowitz MD Circulation; 2004 Sep; 110(12):1518-9. PubMed ID: 15381656 [No Abstract] [Full Text] [Related]
5. Implantation of cardiac rhythm devices without interruption of oral anticoagulation compared with perioperative bridging with low-molecular weight heparin. Tischenko A; Gula LJ; Yee R; Klein GJ; Skanes AC; Krahn AD Am Heart J; 2009 Aug; 158(2):252-6. PubMed ID: 19619702 [TBL] [Abstract][Full Text] [Related]
6. Comparison of safety of subcutaneous enoxaparin as outpatient anticoagulation bridging therapy in patients with a mechanical heart valve versus patients with nonvalvular atrial fibrillation. Bui HT; Krisnaswami A; Le CU; Chan J; Shenoy BN Am J Cardiol; 2009 Nov; 104(10):1429-33. PubMed ID: 19892063 [TBL] [Abstract][Full Text] [Related]
7. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience]. Míka P; Behounek J; Skoták M; Nevsímal L Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102 [TBL] [Abstract][Full Text] [Related]
8. Standardized low-molecular-weight heparin bridging regimen in outpatients on oral anticoagulants undergoing invasive procedure or surgery: an inception cohort management study. Pengo V; Cucchini U; Denas G; Erba N; Guazzaloca G; La Rosa L; De Micheli V; Testa S; Frontoni R; Prisco D; Nante G; Iliceto S; Circulation; 2009 Jun; 119(22):2920-7. PubMed ID: 19470892 [TBL] [Abstract][Full Text] [Related]
9. Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: a prospective multicenter cohort study. Dentali F; Pignatelli P; Malato A; Poli D; Di Minno MN; Di Gennaro L; Rancan E; Pastori D; Grifoni E; Squizzato A; Siragusa S; Di Minno G; Ageno W Am J Hematol; 2012 Apr; 87(4):384-7. PubMed ID: 22367852 [TBL] [Abstract][Full Text] [Related]
10. Out of hospital antithrombotic prophylaxis after total hip replacement: low-molecular-weight heparin, warfarin, aspirin or nothing? A cost-effectiveness analysis. Sarasin FP; Bounameaux H Thromb Haemost; 2002 Apr; 87(4):586-92. PubMed ID: 12008939 [TBL] [Abstract][Full Text] [Related]
11. Variations in perioperative warfarin management: outcomes and practice patterns at nine hospitals. Jaffer AK; Brotman DJ; Bash LD; Mahmood SK; Lott B; White RH Am J Med; 2010 Feb; 123(2):141-50. PubMed ID: 20103023 [TBL] [Abstract][Full Text] [Related]
12. Cancer patients requiring interruption of long-term warfarin because of surgery or chemotherapy induced thrombocytopenia: the use of fixed sub-therapeutic doses of low-molecular weight heparin. Saccullo G; Malato A; Raso S; Santoro M; Zammit V; Casuccio A; Siragusa S Am J Hematol; 2012 Apr; 87(4):388-91. PubMed ID: 22374861 [TBL] [Abstract][Full Text] [Related]